South Korea-based healthcare company Yuyu Pharma announced on Tuesday that it has completed a strategic investment in Dalan Animal Health, a US-based biotechnology company advancing an innate immunity-based platform for developing vaccines for honeybees and shrimp.

This investment will enable the company to continue to expand its platform across new species, exploring novel applications for poultry as well as other aquaculture species.

Robert Wonsang Yu, CEO of Yuyu Pharma, said: "Yuyu Pharma is moving decisively into new areas of animal health where scientific innovation can create lasting global impact. Bees, shrimp, and other essential species play foundational roles in food systems and environmental stability. Our investment in Dalan reflects a clear ambition: to engage directly with technologies that will shape the next generation of global animal health solutions."